Correction to: Genetics in Medicine 2022; https://doi.org/10.1038/s41436-021-01156-3
In the article “One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency” by Diaz GA et al (Genet Med 2021;23:1543-1550), there were two typographical errors. In the “Exploratory efficacy, Spleen and liver volume” section, the mean baseline liver volume is incorrectly typed as 2.2 ± 0.7 MN; the correct value is 2.7 ± 0.7 MN. In the “Pharmacodynamics” section, the unit for the lyso-sphingomyelin normal value is incorrect in one place in the text; it is typed as (ULN 9.99 μg/mL and 181 μmol/L/hr) and it should be (ULN 9.99 μg/L and 181 μmol/L/hr).
Article info
Identification
Copyright
© 2022 Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectLinked Article
- One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiencyGenetics in MedicineVol. 23Issue 8Open Access
